GENERAL CONCEPT AND METHODOLOGY OF DEVELOPING SOLID MEDICINES PLANT EXTRACTS FOR THE TREATMENT OF CARDIOVASCULAR VESSELS
DOI:
https://doi.org/10.53933/sspmpm.v1i2.33Keywords:
general concept and research methodology, plant extracts, solid medicines, tablets, phytopreparations, cardiovascular diseasesAbstract
The role and place of different directions of pharmacotherapy and phytotherapy in the modern system of medical practice always determines their capabilities in several aspects, including treatment of acute diseases, treatment of chronic diseases in remission (antirelapse therapy) and disease prevention. Phytotherapy of diseases of the cardiovascular system (CVS) is mainly based on the use of medicinal plants capable of exhibiting a wide range of therapeutic effects.
In the pharmacotherapy of cardiac arrhythmias are usually used plants that can exhibit vasodilating, cardiotonic, sedative and antiarrhythmic effects. Despite the significant market segment of modern original synthetic drugs (PHs), phytopreparations are gaining relevance in practical medicine, interest in which is revived at a new scientific and practical level through in-depth study of various groups of biologically active natural compounds with a wide range of therapeutic activity , which clearly shows the trend towards the introduction of evidence-based medicine in the overall assessment of the effectiveness of LRS and developed on its basis phytopreparations of various directions.
The article is devoted to the substantiation of the general concept and development of research methodology for the development of solid drugs with plant extracts for the treatment of cardiovascular diseases.
Based on the analysis of modern scientific sources and on the basis of our own experimental research, we have proposed a general concept and methodology for creating solid drugs in tablet form, developed on the basis of parsnip sowing extract and intended for complex use in the treatment of cardiovascular disease. Conceptual approaches to the definition of objects from medicinal plant raw materials of the planned research, obtaining a thick extract and creating on its basis a drug in the form of tablets under the conditional name "Pastinocard" are presented.
References
Ara Tachjian, Viqar Maria, Arshad Jahangir. Use of Herbal Products and Potential Interactions in Patients With Cardiovascular Diseases // J Am Coll Cardiol. 2010 Feb, 55 (6) 515–525. https://www.jacc.org/doi/full/10.1016/j.jacc.2009.07.074.
Kukhtenko O.S. Metodolohichni, tekhnolohichni, biofarmatsevtychni aspekty rozrobky skladnykh ekstraktiv ta likarskykh zasobiv na yikh osnovi: dys. d-ra farmats. nauk: 15.00.01. – Kharkiv, 2019. – 552 s.
Korniievskyi Yu.I., Kraidashenko O.V., Krasko M.P. et al. Fitoterapiia v kardiolohii: navch. posibnyk. – Zaporizhzhia: Vyd-vo ZDMU, 2017. – 470 s.
Mudrak I.H. Metodyka zabezpechennia informatsiieiu pro roslynni likarski zasoby za danymy dokazovoi medytsyny: inform. lyst. Ukrmedpatentinform. Kyiv, 2008. 3 s.
Harna S.V., Vladymyrova I.M., Burd N.B. et al. Suchasna fitoterapiia: navch. posib. Kharkiv: “Drukarnia Madryd”, 2016. – 580 s.
Popova N.V., Litvenenko V.I. Lekarstvennye rastenija mirovoj flory. Harkov: Disa-pljus, 2016. – 540 s.
Sakhanda I.V. Marketynhovyi analiz roslynnoi syrovyny, shcho vkhodyt do skladu likarskykh preparativ dlia likuvannia zakhvoriuvan sertsevo-sudynnoi systemy. Suchasni dosiahnennia farmatsevtychnoi tekhnolohii ta biotekhnolohii: zbirnyk naukovykh prats. X.: Vyd-vo NFaU, 2016. S. 502-505.
Vasenda M.M.. Modern status of the production of phitopreparations.. Pharmaceutical Review. 2013. No. 4. P. 143-147.
Khokhlova K.O., Vyshnevska L.I., Naboka O.I. et al. Obhruntuvannia skladu nastoiky skladnoi «Aterofit-norma» dlia terapii sertsevo-sudynnykh zakhvoriuvan. Ukrainian journal of Clinical and Laboratory Medicine. 2012. Is. 7, No. 4. – P. 212-217.
Barnes J., Anderson L. A., Phillipson J. D. Herbal Medicines. 3rd ed. London: Pharmaceutical Press, 2007. P. 721.
Liapunov M., Bezuhla O., Pidpruzhnykov Yu. et al. Likarski zasoby. Farmatsevtychna rozrobka (ICH Q8): Nastanova ST-N MOZU 42-3.0:2011. Vyd–nia ofitsiine. Ministry of Health of Ukraine. 2011. 33 s.
Bezuglaja E.P., Ljapunov N.A., Bovtenko V.A.. Metodologicheskij podhod k farmacevticheskoj razrabotke lekarstvennyh preparatov i ego standartizacija. Promyshl. obozrenie. 2008. N. 6. – S. 36– 41.
Andriukova L.M., Rusanova S.V., Fetisova O.H. et al. Zahalna otsinka ryzykiv dlia yakosti protsedury bioveiver : metod. rek. dlia sem. i prakt. zaniat ta sam. roboty za napriamom «Promyslova farmatsiia ta ekonomika» v systemi pisliadyplomnoi osvity spetsialistiv farmatsii. Kharkiv : NFaU, 2020. 53 s.
Symonenko N.A., Shpychak O.S. Do pytannia provedennia otsinky systemy upravlinnia ryzykamy dlia yakosti protsesiv vyrobnytstva u tverdykh likarskykh formakh na etapi farmatsevtychnoi rozrobky. Upravlinnia yakistiu v farmatsii: mater. XV nauk.-prakt. konferentsii z mizhnar. uchastiu, m. Kharkiv, 25 travnia 2021 r. Kharkiv : NFaU, 2021. – S. 124-125.
Andriukova L.M., Fetisova O.H., Shpychak O.S. et al. Doslidzhennia bioekvivalentnosti likarskykh zasobiv za protseduroiu bioveiver na pidstavi Biofarmatsevtychnoi systemy klasyfikatsii: metod. rek. dlia sem. i prakt. zaniat ta sam. roboty za napriamom «Promyslova farmatsiia ta ekonomika» v systemi pisliadyplomnoi osvity spetsialistiv farmatsii. Kharkiv : NFaU, 2020. 34 s.
Shpychak O.S., Andriukova L.M., Fetisova O.H. et al. Ohliad zmin shchodo derzhavnoi reiestratsii likarskykh zasobiv u normatyvnykh dokumentakh v Ukraini. Aktualni problemy rozvytku haluzevoi ekonomiky ta lohistyky: mater. IX mizhnarod. nauk.-prakt. internet-konferentsii z mizhnar. uchastiu, Kharkiv, 28 zhovtnia 2021. Kharkiv: NFaU, 2021. – S. 184-186.
Order of the Ministry of Health of Ukraine dated September 13, 2010 No. 769 "On approval of the Concept of development of the pharmaceutical sector of the healthcare sector of Ukraine for 2011-2020". Ministry of Health of Ukraine. URL: https://zakon.rada.gov.ua/rada/show/v0769282-10#Text.
Fetisova O.H., Andriukova L.M., Symonenko N.A. ta in. Ohliad zmin u suchasnii normatyvnii bazi shchodo zabezpechennia yakosti likarskykh zasobiv. Upravlinnia yakistiu v farmatsii: mater. XV nauk.-prakt. konferentsii z mizhnar. uchastiu, m. Kharkiv, 25 travnia 2021 r. Kharkiv: NFaU, 2021. – S. 142-143.
State Register of Medicines of Ukraine. Ministry of Health of Ukraine. URL: http://www.drlz.kiev.ua.
Minarchenko V.M., Butko A.Yu. Study on domestic market of medicinal products of plant origin. Farmatsevtychnyi zhurnal. 2017. No. 1. P. 30-36.
Shostak T.A., Kalyniuk T.G., Huz N.I. Aspects of pharmaceutical development of herbal medicines (Library review). Fitoterapiia. Chasopys. 2014. No. 4. P. 77-82.
Compendium. Medications. URL: https://compendium.com.ua/atc/.
Horiacha L.M., Symonenko N.A., Haluzinska L.V. et al. Doslidzhennia kardioprotektornoi dii pasternaku posivnoho travy ekstraktu hustoho. Ukrainskyi biofarmatsevtychnyi zhurnal. 2020. N. 4 (65). S. 46–50.
Horiacha L.M., Kyslychenko V.S., Symonenko N.A. et al. Oderzhannia ekstraktu z travy pasternaku posivnoho (Pastinaca Sativa L.). Suchasni dosiahnennia farmatsevtychnoi nauky v stvorenni ta standartyzatsii likarskykh zasobiv i diietychnykh dobavok, shcho mistiat komponenty pryrodnoho pokhodzhennia: materialy III Mizhnar. nauk.-prakt. internet-konf. (2 kvitnia 2021 r., m. Kharkiv). – Elektron. dani. – X.: NFaU, 2021. – S. 77.
Symonenko N.A., Shpychak O.S. Rozrobka tekhnolohii ta metodiv standartyzatsii roslynnoi substantsii pasternaku posivnoho travy ekstraktu hustoho. Fundamentalni ta prykladni doslidzhennia u haluzi farmatsevtychnoi tekhnolohii: materialy I Mizhnarodnoi naukovo-praktychnoi konferentsii (m. Kharkiv, 13 zhovtnia 2021 r.). Kh.: Vyd-vo NFaU, 2021. – S. 170-172.
Symonenko N.A., Shpychak O.S., Ruban O.A. et al. Obhruntuvannia vyboru dopomizhnykh rechovyn pry rozrobtsi skladu tabletok z roslynnoi substantsii pasternaku posivnoho travy ekstraktu hustoho. Tekhnolohichni ta biofarmatsevtychni aspekty stvorennia likarskykh preparativ riznoi napravlenosti dii: materialy VI Mizhnarodnoi naukovo-praktychnoi internet-konferentsii (m. Kharkiv, 11-12 lystopada 2021 r.). Kh.: Vyd-vo NFaU, 2021. – S. 449-450.
Alkhalaf M.V., Ruban О.A., Gerbina N.A. et al. Studies of physico-chemical and pharmacotechnological properties of Zingiber officinale dry extract. Journal of Pharmaceutical Science and Research. 2018. Vol. 10 (1). P. 5–7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Natalia Symonenko, Oleh Shpychak
This work is licensed under a Creative Commons Attribution 4.0 International License.
